Title : Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.

Pub. Date : 1990

PMID : 1693316






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a phase II study, coordinated at the West Midlands CRC Clinical Trials Unit, Birmingham, using ifosfamide (IFX) in combination with cisplatin and bleomycin (BIP) in advanced and recurrent cervical cancer, we demonstrated a response rate of 69%. Bleomycin heat shock protein family A (Hsp70) member 5 Homo sapiens